Small Heterodimer Partner Negatively Regulates TLR4 Signaling Pathway of Titanium Particles-Induced Osteolysis in...

Area of Science:

• Biomedical Engineering
• Immunology
• Orthopedics

Background:

• Arthroplasty failure is often caused by wear particle-induced osteolysis and aseptic loosening.
• Macrophages activated by wear particles play a key role in this inflammatory process.

Purpose of the Study:

• To investigate the role of small heterodimer partner (SHP) in macrophage-mediated inflammatory responses to wear particles.
• To elucidate the involvement of SHP in the Toll-like Receptor (TLR) signaling pathway.

Main Methods:

• Utilized RAW264.7 macrophage cell line and a mouse model with SHP gene overexpression.
• Analyzed the expression of TLR4, TRAF6, NEMO complex, and TNF-α in response to titanium wear particles.
• Assessed the effect of SHP modulation on wear particle-induced cranial osteolysis in vivo.

Main Results:

• Wear particle stimulation upregulated TLR4, TRAF6, NEMO, and TNF-α while downregulating SHP.
• SHP inhibition enhanced NEMO and TNF-α expression, whereas SHP overexpression suppressed them.
• Overexpression of SHP significantly inhibited cranial osteolysis induced by wear particles in mice.

Conclusions:

• SHP acts as a negative regulator of the TLR4 signaling pathway.
• SHP downregulates inflammatory cytokine secretion, thereby reducing wear particle-induced osteolysis.
• Targeting SHP may offer a therapeutic strategy to prevent long-term prosthetic failure.